Dying company - Associate Director of Data Science Novartis Employee Review

1.0
Jun 2, 2023
Recommend
CEO approval
Business Outlook

Pros

Office is very nice and kind colleagues

Cons

Dying company in a dying sector. Competitors are stronger and eating our market share for breakfast. We are years behind in R&D

Explore other reviews about Novartis

5.0
May 16, 2026
Recommend
CEO approval
Business Outlook

Pros

people are friendly and easy to work with

Cons

daily commute takes longer than expected

2.0
Jun 25, 2026
Recommend
CEO approval
Business Outlook

Pros

Good Products to represent and many opportunities for advancement

Cons

Poor culture, Poor Leadership. Restructuring every year or two.

See reviews by: Helpful|Rating|Date|All